AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 40 filers reported holding AIM IMMUNOTECH INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $321,979 | -32.1% | 707,646 | +0.0% | 0.00% | – |
| Q2 2023 | $474,054 | +34.9% | 707,544 | -13.4% | 0.00% | – |
| Q1 2023 | $351,365 | +38.4% | 817,127 | +0.4% | 0.00% | – |
| Q4 2022 | $253,801 | -46.3% | 813,726 | +0.0% | 0.00% | – |
| Q3 2022 | $473,000 | -25.9% | 813,460 | -0.4% | 0.00% | – |
| Q2 2022 | $638,000 | -27.3% | 816,702 | -1.4% | 0.00% | – |
| Q1 2022 | $878,000 | +14.5% | 828,543 | -0.7% | 0.00% | – |
| Q4 2021 | $767,000 | -54.2% | 834,303 | +0.7% | 0.00% | – |
| Q3 2021 | $1,673,000 | -5.4% | 828,158 | +0.7% | 0.00% | – |
| Q2 2021 | $1,769,000 | -20.4% | 822,690 | -16.0% | 0.00% | – |
| Q1 2021 | $2,223,000 | +143.2% | 979,042 | +91.7% | 0.00% | – |
| Q4 2020 | $914,000 | -15.4% | 510,796 | +1.6% | 0.00% | – |
| Q3 2020 | $1,080,000 | -8.5% | 502,692 | +5.7% | 0.00% | – |
| Q2 2020 | $1,180,000 | +4270.4% | 475,602 | +4418.8% | 0.00% | – |
| Q1 2020 | $27,000 | +350.0% | 10,525 | 0.0% | 0.00% | – |
| Q4 2019 | $6,000 | -25.0% | 10,525 | 0.0% | 0.00% | – |
| Q3 2019 | $8,000 | – | 10,525 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| XTX MARKETS LLC | 11,019 | $20,000 | 0.04% |
| Virtu Financial LLC | 103,807 | $186,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 10,000 | $18,000 | 0.01% |
| SeaCrest Wealth Management, LLC | 48,873 | $87,000 | 0.01% |
| Arkadios Wealth Advisors | 20,000 | $35,000 | 0.01% |
| Traynor Capital Management, Inc. | 14,777 | $26,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 17,047 | $31,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 111,000 | $199,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 20,200 | $36,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 12,513 | $22,000 | 0.00% |